Zu unserem Team

Elaine Riddell

Geschäftsführer

Elaine is a managing director at Oaklins DeSilva+Phillips in New York. She has deep operational expertise in the data, analytics and insights-led consulting industry supporting healthcare and, in particular, life sciences as well as consumer-driven sectors and on a global basis. Elaine brings an understanding of the disruptive market dynamics shaping these industries and influencing M&A priorities and spending. This highly relevant market knowledge has enabled insights and healthcare teams to be invited to pitch and to win a majority of these new pitches.

Prior to joining Oaklins DeSilva+Phillips in 2020, Elaine was a divisional CEO for 15 years at Kantar Health (now Oracle Cerner Enviza), TNS Healthcare (acquired by Kantar) and NOPWorld Health, a unit of UBM. She is recognized as an industry innovator who transforms mature, stagnant, global data, analytics and insights-led consulting firms into high-performing, scaled market leaders with sustained, profitable revenue growth at three times the market rate. Elaine draws on her experience at Abbott Labs (now AbbVie), a top 10 pharmaceutical company, and IMS Health (now IQVIA), the leading multinational health information and technology firm. This breadth of experience forms the foundation of her growth advisory serving founder/CEOs and private equity firms, and her contribution to M&A advisory and successful transactions.

 Elaine  Riddell
Standort
New York, Vereinigte Staaten

E-Mail


Telefon
+1 212-651-2562

Rare Patient Voice has been acquired by Konovo
Gesundheitswesen | Technologie, Medien und Telekommunikation

Rare Patient Voice has been acquired by Konovo

Weitere Informationen
Epicenter has been acquired by Stagwell
Technologie, Medien und Telekommunikation

Epicenter has been acquired by Stagwell

Weitere Informationen
Helixa has been acquired by Telmar
Private Equity | Technologie, Medien und Telekommunikation

Helixa has been acquired by Telmar

Weitere Informationen